Among the diverse types of receptors within the Eph family, the EphA2 transformation of normal cells into malignant, angiogenesis, and metastasis has been comprehensively studied in many types of cancers, such as melanoma, glioblastoma, and breast cancer [12]. This evidence concerns the gene EPHA1 and breast cancer.